Fund profile
Tickers
PILL
Fund manager
Total assets
$16.26 mm
Liabilities
$2.20 mm
Net assets
$14.06 mm
Number of holdings
41.00
PILL stock data
41 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | 3.32 mm | 3.32 mm principal | 23.63 | Short-term investment vehicle | Long | USA |
GOLDMAN SACHS FIN GOV 465 INSTITUT | 1.04 mm | 1.04 mm principal | 7.40 | Short-term investment vehicle | Long | USA |
OGN Organon & Co. | 620.68 k | 37.28 k shares | 4.41 | Common equity | Long | USA |
S&P PHARMACEUTICALS SELECT INDEX SWAP
UBS AG
|
606.74 k | 1.00 contracts | 4.31 | Equity derivative | N/A | USA |
CTLT Catalent Inc. | 570.42 k | 11.05 k shares | 4.06 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 526.86 k | 5.85 k shares | 3.75 | Common equity | Long | USA |
VTRS Viatris Inc | 491.83 k | 41.79 k shares | 3.50 | Common equity | Long | USA |
MRK Merck & Co Inc | 478.65 k | 3.96 k shares | 3.40 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 473.07 k | 32.09 k shares | 3.36 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 458.65 k | 6.81 k shares | 3.26 | Common equity | Long | USA |
PRGO Perrigo Company plc | 444.53 k | 13.86 k shares | 3.16 | Common equity | Long | Ireland |
LLY Lilly(Eli) & Co | 442.24 k | 685.00 shares | 3.14 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 434.56 k | 18.48 k shares | 3.09 | Common equity | Long | USA |
JNJ Johnson & Johnson | 422.67 k | 2.66 k shares | 3.01 | Common equity | Long | USA |
S&P PHARMACEUTICALS SELECT INDEX SWAP
Citibank National Association
|
420.98 k | 1.00 contracts | 2.99 | Equity derivative | N/A | USA |
JAZZ Jazz Pharmaceuticals plc | 418.72 k | 3.41 k shares | 2.98 | Common equity | Long | Ireland |
ZTS Zoetis Inc - Ordinary Shares | 418.25 k | 2.23 k shares | 2.97 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 408.16 k | 14.38 k shares | 2.90 | Common equity | Long | UK |
BMY Bristol-Myers Squibb Co. | 398.88 k | 8.16 k shares | 2.84 | Common equity | Long | USA |
PFE Pfizer Inc. | 386.51 k | 14.27 k shares | 2.75 | Common equity | Long | USA |
S&P PHARMACEUTICALS SELECT INDEX SWAP
Barclays Bank PLC
|
324.36 k | 1.00 contracts | 2.31 | Equity derivative | N/A | USA |
AMLX Amylyx Pharmaceuticals Inc | 293.98 k | 18.37 k shares | 2.09 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 233.30 k | 7.40 k shares | 1.66 | Common equity | Long | USA |
GOLDMAN FINL SQ TRSRY INST 506 | 217.74 k | 217.74 k principal | 1.55 | Short-term investment vehicle | Long | USA |
SAVA Cassava Sciences Inc | 213.97 k | 8.93 k shares | 1.52 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 203.26 k | 6.24 k shares | 1.45 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals Inc | 194.23 k | 3.64 k shares | 1.38 | Common equity | Long | USA |
CORT Corcept Therapeutics Inc | 178.00 k | 8.44 k shares | 1.27 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc | 169.48 k | 2.75 k shares | 1.21 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 144.17 k | 28.66 k shares | 1.03 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 138.32 k | 5.00 k shares | 0.98 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 138.24 k | 5.08 k shares | 0.98 | Common equity | Long | USA |
ARVN Arvinas Inc | 126.12 k | 3.04 k shares | 0.90 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 119.37 k | 6.66 k shares | 0.85 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 118.51 k | 2.12 k shares | 0.84 | Common equity | Long | USA |
INVA Innoviva Inc | 109.48 k | 6.76 k shares | 0.78 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 93.08 k | 2.82 k shares | 0.66 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 82.09 k | 1.12 k shares | 0.58 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals Inc - Ordinary Shares | 63.27 k | 11.83 k shares | 0.45 | Common equity | Long | USA |
EOLS Evolus Inc | 62.33 k | 4.91 k shares | 0.44 | Common equity | Long | USA |
TBPH Theravance Biopharma Inc | 42.20 k | 4.45 k shares | 0.30 | Common equity | Long | Cayman Islands |